RecruitingNot ApplicableNCT05269589

Home-based Heat Therapy for Type 2 Diabetes

Impact of a Home-based Heat Therapy Intervention on Markers of Cardiometabolic Function in Adults with Type 2 Diabetes


Sponsor

Montreal Heart Institute

Enrollment

44 participants

Start Date

Feb 18, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Insulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in individuals with T2DM persists despite optimal pharmacological therapy, highlighting the need to identify complementary lifestyle interventions that improve cardiometabolic functions in this population. Evidence from animal models suggests that heat exposure improves metabolic functions. Notably, weekly heat exposure for 16 weeks blunts hyperinsulinemia and hyperglycemia induced by a high fat diet in mice. In parallel, studies in humans have shown that heat exposure improves vascular endothelial function. Based on such findings, it has been suggested that heat therapy may represent an effective lifestyle intervention to improve cardiometabolic functions. However, only 1 study has examined the impact of a heat therapy intervention on individuals with T2DM, demonstrating that 6 weeks of heat exposure reduces fasting plasma glucose and hemoglobin A1C. No study has considered potential vascular benefits of heat therapy in individuals with T2DM. This project will investigate cardiometabolic responses to repeated heat exposure in men and women with T2DM. We will test the hypothesis that 12 weeks of heat therapy improves postprandial fatty acid handling, insulin sensitivity and endothelial function in individuals with T2DM.


Eligibility

Min Age: 45 YearsMax Age: 75 Years

Inclusion Criteria3

  • Age 45-75 years
  • Diagnosis of type 2 diabetes mellitus ≥1 year
  • Stable medication ≥12 weeks

Exclusion Criteria7

  • Class 3 obesity
  • Hypertension not controled by medication
  • Diagnosis of cardiac, renal and/or pulmonary disease
  • Diagnosis of severe neuropathy and/or retinopathy
  • Insulin therapy
  • Fasting plasma triglycerides \>5.0 mmol/L
  • Fasting total cholesterol \>7 mmol/l

Interventions

OTHERThermoneutral water

Participants will immerse their feet in a foot bath that contains thermoneutral water

OTHERHot water

Participants will immerse their feet in a foot bath that contains hot water


Locations(1)

Centre ÉPIC, Montreal Heart Institute

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05269589


Related Trials